By 2026, every research peptide vendor online claimed the same purity numbers. Third-party verification, ISO-certified labs, HPLC and Mass Spec. The claims became noise because almost none of them were backed by accessible, batch-specific documentation a researcher could actually verify.
The catalog is curated, not exhaustive: 21 HPLC-tested SKUs across five mechanism classes. Compounds are organized into literature-referenced groupings drawn from published in vitro research. Every compound on the catalog has a documented research basis for being there.
SYNGEN was built around verifiable documentation. Every batch is tested by an independent ISO 17025-certified laboratory before it ships. Every Certificate of Analysis is published in a public, batch-specific library, searchable by product and lot number, accessible without an account. The laboratory name and accreditation number appear on every certificate so the result can be independently confirmed.
This is what the research peptide space was missing. Not better marketing. Verifiable documentation, openly published, on every batch.